North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications
Payam Dehghani(Genome Prairie), Timothy D. Henry(Christ Hospital), Perwaiz Meraj(Hofstra University), Laura Davidson(American College of Cardiology), Santiago García(Minneapolis VA Health Care System), Christian Schmidt(Minneapolis Heart Institute Foundation), Cindy L. Grines(Northside Hospital), Scott W. Sharkey(Abbott Northwestern Hospital), Frederick G.P. Welt(Harvard University), Prashant Kaul(Piedmont Atlanta Hospital), Keshav R. Nayak(Scripps Mercy Hospital), Binita Shah(New York University), Akshay Bagai(St. Michael's Hospital), Ross Garberich(Minneapolis Heart Institute Foundation), Jacqueline Saw(University of British Columbia), David Wood(Valve (United States)), Jay Giri(Hospital of the University of Pennsylvania), Hung Q. Ly(Duy Tan University), Ehtisham Mahmud(Cardiovascular Institute of the South)
Cited by 47
Related Papers
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
Adv. Drug Delivery Rev.
|Advanced Drug Delivery Reviews|1997|863